Genetic: Studies demonstrate that MS has a strong genetic base. The first degree family of a MS patient is at a 10-25 times greater risk than normal population, so genetically susceptible people are more likely to develop MS disease.[3][4]
Gender: Prevalence of MS disease is higher in female. This can be hormone related or more susceptibility to environmental risk factors.[5][6]
Vitamin D: Low vitamin D level seems to be a risk factor for developing MS since the prevalence of MS is lower in regions where people take vitamin D supplement or have higher sunlight exposure.[7][8]
Stress: Stressful life events can be a risk factor for MS disease. In patients who already have MS, stress and anxiety can lead to exacerbation of their disease.[9][10]
↑Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, Ascherio A (January 2004). "Vitamin D intake and incidence of multiple sclerosis". Neurology. 62 (1): 60–5. PMID14718698.
↑Coo H, Aronson KJ (2004). "A systematic review of several potential non-genetic risk factors for multiple sclerosis". Neuroepidemiology. 23 (1–2): 1–12. doi:10.1159/000073969. PMID14739563.
↑Goodin DS, Ebers GC, Johnson KP, Rodriguez M, Sibley WA, Wolinsky JS (June 1999). "The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology". Neurology. 52 (9): 1737–45. PMID10371517.
↑Kurtzke JF, Beebe GW, Norman JE (September 1979). "Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution". Neurology. 29 (9 Pt 1): 1228–35. PMID573402.
↑Sundström P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nyström L, Dillner J, Forsgren L (June 2004). "An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study". Neurology. 62 (12): 2277–82. PMID15210894.
↑Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A (May 2005). "Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis". JAMA. 293 (20): 2496–500. doi:10.1001/jama.293.20.2496. PMID15914750.